| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |